Cannabis Law Report

NOVEMBER 16, 2021

Phase 2 trial recruiting begins immediately; efficacy data expected by the end of the first quarter of 2022. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Recruitment for the Phase 2 trial will begin immediately, and efficacy data is expected by the end of first quarter of 2022. “To MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. In 2021, CBD sales in the natural channel totaled $38,931,696, a 24% decline.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Chronicles

JANUARY 2, 2019

drug regulators approved the first marijuana-based pharmaceutical to treat kids with a form of epilepsy, and billions of investment dollars poured into cannabis companies. With buzz building across the globe, the momentum will continue into 2019. Even main street brands like Coca-Cola are considering joining the party. “I

Legalization 100

Legalization Research and Development Recreational Data 100

Cannabis Law Report

DECEMBER 9, 2019

Although official uses (outside of treatment for childhood epilepsy) have not been officially approved by the FDA, early results from research has resulted in consumers flocking to the compound of their own accord and at their own risk. Millions of individuals are reporting CBD having aided in helping them with: Anxiety.

Pets 59

Pets CBD Research and Development Epilepsy 59

Veriheal

MARCH 23, 2023

Japan’s latest Cannabis Control Law revisions would apply to pharmaceutical-grade medicinal cannabis products. The report states that the revision is an essential move for ensuring the legal use of cannabis-derived epilepsy drug Epidiolex , which is currently being reviewed as part of a series of clinical trials in Japan.

Legalization 66

Legalization Marijuana Clinical Trials Seed-To-Sale 66

NORML

AUGUST 26, 2019

There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. And, 2019’s SB 1557 makes it possible for patients to get as much as 10mg of THC in each dose — the same limit as one serving size for edibles in adult-use states.

Marijuana 208

Marijuana Legalization Programs Oil 208

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. Shutterstock). One of the leading cannabis clinicians in the U.S.,

CBD 122

CBD Research and Development Epilepsy Extraction 122

CannaTech

SEPTEMBER 23, 2019

Israeli patients protest IMCA’s medical cannabis reforms at CannaTech Tel Aviv 2019. The group’s misguided conclusions are a strawman: prohibition of cannabis and the requirements of Helsinki have severely limited research into the plant’s potential medical applications, ergo less gold-standard randomized controlled clinical trial data.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Cannabis Law Report

MAY 7, 2019

March 04, 2019 13:32 ET | Source: Veritas Pharma Inc. VANCOUVER, British Columbia, March 04, 2019 (GLOBE NEWSWIRE) — Veritas Pharma Inc. is an emerging pharmaceutical and IP development company, who, through its 100% owned subsidiary Cannevert Therapeutics Ltd. (“CTL“), plus accrued interest. Veritas Pharma Inc.

Compliance 63

Compliance Compliance Research and Development Strains 63

Cannabis Law Report

NOVEMBER 24, 2021

Using a content analysis approach, we investigated articles about medicinal cannabis from 2000 to the end of 2019 in the Medical Journal of Australia, Australian Doctor , Medical Observer , Australian Journal of General Practice , Australian Family Physicia n , and Australian Medicine. Refractory paediatric epilepsy.

Research and Development 52

Research and Development Medicine Access Media 52

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. A 2019 study found that 76% of patients in the U.S. Findings from the CDC’s 2019 National Health Interview Survey report that 20.4% This trend dates back to the 1990s when U.S.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Veriheal

JULY 5, 2021

The self-reported data was logged between June 6, 2016, and July 8, 2019. The UNM researchers noted that, since nausea is just one symptom, CBD may be a better option for relieving the symptoms associated with other types of medical conditions, such as epilepsy and chronic pain. Motion sickness.

THC 52

THC CBD Treatment Cannabinoids 52

Cannabis Law Report

SEPTEMBER 19, 2019

Joshua Warner | Writer , London | Wednesday 18 September 2019 00:53. Medicinal cannabis was technically legalised at the start of November 2018 following several high-profile cases about children with severe forms of epilepsy being unable to access potentially life-changing cannabis-based treatment. GW Pharmaceuticals ?and

Pharmaceutical 40

Pharmaceutical Research and Development Medicine Oil 40

Puff Puff Post

DECEMBER 28, 2018

An official study is aimed to conclude in July of 2019, where we’ll see all the data which comes forth. Influencing how information is processed and how nerve cells and synapses in the brain interact, the exact function related to autism is still not well understood, and no pharmaceuticals around yet can ‘fix’ autism.

Treatment 76

Treatment Oil CBD Therapy 76

Puff Puff Post

DECEMBER 2, 2019

The FDA’s Consumer Update reiterated that, with the exception of Epidiolex (a CBD drug for rare forms of epilepsy), the FDA hasn’t approved any other forms of CBD. This is mainly due to a lack of data. Another estimated that the global market will have grown 40% from last year by the time 2019 comes to a close.

CBD 52

CBD Food Pets Safety 52

CannaTech

OCTOBER 14, 2018

The bill, scheduled to take effect on January 1, 2019, allows California farmers to enter the rapidly-growing hemp industry on a wide scale, raising industrial hemp to produce hemp seed, oil, fiber, and extract for a variety of uses. billion by 2022, according to New Frontier Data, a premier cannabis data analytics firm.

Hemp 53

Hemp Research and Development Agriculture Seed-To-Sale 53

Cannabis Law Report

OCTOBER 26, 2019

The TGA does not evaluate any data relating to the trial. vi Regulatory incentivesPatent term extensionThe Patents Act 1990 provides that in situations where the time taken for regulatory approval of a pharmaceutical substance claimed by the patent exceeds five years, the term of the patent may be extended.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

MARCH 3, 2020

Courtney Parker, Pensacola Store Manager amplifies this goal: “At MÜV our main priority is to combine pharmaceutical industry precision with an engaging and compassionate patient experience. Maria Denzin wrote a Cannabis Dispensary piece for the May-June 2019 issue titled The Makings of Great Customer Service. FLORIDA FOCUS.

Dispensary 64

Dispensary Patients Cannabis Wellness and Beauty 64

Cannabis Law Report

JANUARY 20, 2022

Earlier in 2021, Eleusis welcomed four new directors to its Board: David Socks, former CEO of Phathom Pharmaceuticals, joining as Chairman, Robert Hershberg, M.D., former CBO and CSO of Celgene, John Tucker, CEO of SC Pharmaceuticals, and Esther van den Boom, Managing Partner at van den Boom & Associates. __.

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Law Report

OCTOBER 17, 2019

When the first physical stores opened six months later in April 2019, legal recreational cannabis sales in the province more than doubled online sales from the previous two months. Another researcher, New Frontier Data, pegged the global value of legal and illicit cannabis together at $340 billion in 2018.

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

MAY 17, 2019

Seq (1970) and Drug Enforcement Administration’s (“DEA”) clutches, 2019 hemp production and sales exploded. A wildly popular nutritional supplement and food additive, oil based hemp derived products like CBD racked up $1.1 Budgeted at $6.1 billion (a $643.1

Food 10

Food DEA Hemp CBD 10